Radioimmunoscintigraphy of colorectal cancer using a two-step pre-targeting method
2009-01-01 Aarts, F; Boerman, Oc; Sharkey, Rm; Hendriks, T; Bleichrodt, Rp; Oyen, W; Goldenberg, Dm
Reproducibility of static FDG-PET in liver metastases of colorectal cancer
2011-01-01 Heijmen, L; van Laarhoven, Hwm; Ter Voert, Eegw; Heerschap, A; De Wilt, Hja; Punt, Cja; Oyen, W; de Geus-Oei, L
VASCULAR HURST INDEX IN NON-TUMORAL BIOPSY CORES AS POTENTIAL HISTOPATHOLOGICAL PARAMETER TO SELECT PATIENTS WITH HIDDEN PROSTATE CANCER
2018-01-01 Grizzi, F; Mandressi, A; Colombo, P; Melegari, S; Justich, M; Bozzini, G; Seveso, M; De Francesco, O; Buffi, N; Lughezzani, G; Lazzeri, M; Hurle, R; Pasini, L; Benetti, A; Zandegiacomo, S; Peschechera, R; Casale, P; Guazzoni, Gf; Taverna, G
A multiprobe approach to monitoring therapy response in rheumatoid arthritis
2015-01-01 Terry, Sya; Koenders, Mi; Nayak, Tk; Freimoser-Grundschober, A; Klein, C; Oyen, W; Boerman, Oc; Laverman, P
FDG-PET/CT to predict outcome of first-line chemotherapy plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer
2016-01-01 Usmanij, E; Natroshvili, T; Timmer-Bonte, J; van der Drift, M; Oyen, W; Bussink, J; De Geus-Oei, Lf
Phase II study of Lutetium-177-labeled anti-Carbonic Anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma.
2016-01-01 Muselaers, S; Boers-Sonderen, M; van Oostenbrugge, T; Boerman, O; Desar, I; Stillebroer, A; Mulder, S; van Herpen, C; Langenhuijsen, J; Oosterwijk, E; Oyen, W; Mulders, P
A PROSPECTIVE, RANDOMIZED, MULTICENTER STUDY COMPARING SEMS PLACEMENT WITH AND WITHOUT BILIARY SPHINCTERECTOMY IN PATIENTS WITH MALIGNANT BILIARY OBSTRUCTION: AN INTERIM ANALYSIS
2019-01-01 Anderloni, Aa; Fugazza, A; D'Amico, F; de Nucci, G; Manes, G; Maselli, R; Mangiavillano, B; Auriemma, F; Belletrutti, Pj; Hassan, C; Maydeo, Ap; Repici, A
ADJUVANT RADIOIMMUNOTHERAPY AFTER RADIOFREQUENCY ABLATION OF COLORECTAL LIVER METASTASES
2010-01-01 De Jong, Gm; Hendriks, T; Oyen, W; Boerman, Oc; Bleichrodt, Rp
Pretargeted immunoPET imaging and radioimmunotherapy (RIT) of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody (bsMAb)
2010-01-01 van Rij, C; Franssen, G; Sharkey, R; Frielink, C; Mcbride, B; Oyen, W; Goldenberg, D; Boerman, O
Vestibular flap urethroplasty for strictures of the female urethra: Impact on symptoms and flow patterns
1998-01-01 Montorsi, F; Cestari, A; Centemero, A; Nava, L; Guazzoni, G; Da Pozzo, L; Rigatti, P
Technical description of sural nerve grafting during laparoscopic radical prostatectomy (VLRP): The video
2003-01-01 Nava, L; Guazzoni, G; Cestari, A; Losa, A; Riva, M; Bellinzoni, P; Rigatti, L; Rigatti, P
Pretargeted radioimmunotherapy of an anti-CEA bispecific antibody and Lu-177-labeled peptide: a phase I study in patients with advanced colorectal cancer
2012-01-01 Schoffelen, R; Boerman, Oc; Goldenberg, Dm; Sharkey, Rm; Herpen, Cml; Chang, Ch; Franssen, Gm; Mcbride, Wj; Rossi, Ea; van der Graaf, Wta; Oyen, W
F-18-fluorodeoxyglucose positron emission tomography of colonic anastomosis: A possibility to detect anastomotic leakage? A pilot study
2012-01-01 Teeuwen, P; de Geus-Oei, Lf; Hendriks, T; van Goor, H; Bremers, A; Oyen, W; Bleichrodt, R
BEVACIZUMAB BEYOND PROGRESSION: HOW TO MONITOR TREATMENT EFFICACY? RESULTS OF A FUNCTIONAL IMAGING STUDY IN MURINE COLORECTAL CANCER
2012-01-01 Heijmen, L; Ter Voert, Eegw; Punt, Cja; De Geus-Oei, L; Heerschap, A; Bussink, J; Zerbi, V; Oyen, W; Boerman, O; van Laarhoven, Hwm
Monitoring the effects of bevacizumab beyond progression in murine colorectal cancer: a functional imaging approach
2012-01-01 Heijmen, L; Punt, Cja; ter Voert, Eegw; de Geus-Oei, L; Heerschap, A; Bussink, J; Zerbi, V; Oyen, W; Span, Pn; Boerman, O; van Laarhoven, Hwm
FLT-PET FOR DETECTION OF EARLY TREATMENT RESPONSE IN CERVICAL LYMPH NODE METASTASES OF HEAD AND NECK TUMOURS
2010-01-01 Troost, E; Bussink, J; Oyen, W; Kaanders, J
Fast and facile purification of Ga-68-labeled compounds using solid-phase extraction
2010-01-01 Brom, M; Franssen, G; Joosten, L; Oyen, W; Gotthardt, M; Boerman, O
Vessels encapsulating tumour clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma (HCC)
2019-01-01 Renne, S; Woo, Hy; Rudini, N; Allegra, S; Yano, H; Donadon, M; Vigano, L; Akiba, J; Lee, Hs; Rhee, H; Park, Yn; Roncalli, M; Di Tommaso, L
Sorafenib reduces the tumor uptake of Indium-111-girentuximab in clear cell renal cell carcinoma patients
2012-01-01 Muselaers, Chj; Stillebroer, Ab; Boers-Sonderen, Mj; Desar, Ime; van Herpen, Cml; Langenhuijsen, Jf; Oosterwijk, E; Boerman, Oc; Mulders, Pfa; Oyen, W
Pretargeting a radiolabeled hapten-peptide with a tri-Fab humanized bispecific antibody (bsMAb) to CEACAM5: First results in patients with colorectal cancer
2010-01-01 Sharkey, R; Schoffelen, R; Esposito, G; He, Aw; Boerman, O; Oyen, W; Weiner, L; Goldenberg, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Radioimmunoscintigraphy of colorectal cancer using a two-step pre-targeting method | 1-gen-2009 | Aarts, F; Boerman, Oc; Sharkey, Rm; Hendriks, T; Bleichrodt, Rp; Oyen, W; Goldenberg, Dm | |
| Reproducibility of static FDG-PET in liver metastases of colorectal cancer | 1-gen-2011 | Heijmen, L; van Laarhoven, Hwm; Ter Voert, Eegw; Heerschap, A; De Wilt, Hja; Punt, Cja; Oyen, W; de Geus-Oei, L | |
| VASCULAR HURST INDEX IN NON-TUMORAL BIOPSY CORES AS POTENTIAL HISTOPATHOLOGICAL PARAMETER TO SELECT PATIENTS WITH HIDDEN PROSTATE CANCER | 1-gen-2018 | Grizzi, F; Mandressi, A; Colombo, P; Melegari, S; Justich, M; Bozzini, G; Seveso, M; De Francesco, O; Buffi, N; Lughezzani, G; Lazzeri, M; Hurle, R; Pasini, L; Benetti, A; Zandegiacomo, S; Peschechera, R; Casale, P; Guazzoni, Gf; Taverna, G | |
| A multiprobe approach to monitoring therapy response in rheumatoid arthritis | 1-gen-2015 | Terry, Sya; Koenders, Mi; Nayak, Tk; Freimoser-Grundschober, A; Klein, C; Oyen, W; Boerman, Oc; Laverman, P | |
| FDG-PET/CT to predict outcome of first-line chemotherapy plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer | 1-gen-2016 | Usmanij, E; Natroshvili, T; Timmer-Bonte, J; van der Drift, M; Oyen, W; Bussink, J; De Geus-Oei, Lf | |
| Phase II study of Lutetium-177-labeled anti-Carbonic Anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma. | 1-gen-2016 | Muselaers, S; Boers-Sonderen, M; van Oostenbrugge, T; Boerman, O; Desar, I; Stillebroer, A; Mulder, S; van Herpen, C; Langenhuijsen, J; Oosterwijk, E; Oyen, W; Mulders, P | |
| A PROSPECTIVE, RANDOMIZED, MULTICENTER STUDY COMPARING SEMS PLACEMENT WITH AND WITHOUT BILIARY SPHINCTERECTOMY IN PATIENTS WITH MALIGNANT BILIARY OBSTRUCTION: AN INTERIM ANALYSIS | 1-gen-2019 | Anderloni, Aa; Fugazza, A; D'Amico, F; de Nucci, G; Manes, G; Maselli, R; Mangiavillano, B; Auriemma, F; Belletrutti, Pj; Hassan, C; Maydeo, Ap; Repici, A | |
| ADJUVANT RADIOIMMUNOTHERAPY AFTER RADIOFREQUENCY ABLATION OF COLORECTAL LIVER METASTASES | 1-gen-2010 | De Jong, Gm; Hendriks, T; Oyen, W; Boerman, Oc; Bleichrodt, Rp | |
| Pretargeted immunoPET imaging and radioimmunotherapy (RIT) of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody (bsMAb) | 1-gen-2010 | van Rij, C; Franssen, G; Sharkey, R; Frielink, C; Mcbride, B; Oyen, W; Goldenberg, D; Boerman, O | |
| Vestibular flap urethroplasty for strictures of the female urethra: Impact on symptoms and flow patterns | 1-gen-1998 | Montorsi, F; Cestari, A; Centemero, A; Nava, L; Guazzoni, G; Da Pozzo, L; Rigatti, P | |
| Technical description of sural nerve grafting during laparoscopic radical prostatectomy (VLRP): The video | 1-gen-2003 | Nava, L; Guazzoni, G; Cestari, A; Losa, A; Riva, M; Bellinzoni, P; Rigatti, L; Rigatti, P | |
| Pretargeted radioimmunotherapy of an anti-CEA bispecific antibody and Lu-177-labeled peptide: a phase I study in patients with advanced colorectal cancer | 1-gen-2012 | Schoffelen, R; Boerman, Oc; Goldenberg, Dm; Sharkey, Rm; Herpen, Cml; Chang, Ch; Franssen, Gm; Mcbride, Wj; Rossi, Ea; van der Graaf, Wta; Oyen, W | |
| F-18-fluorodeoxyglucose positron emission tomography of colonic anastomosis: A possibility to detect anastomotic leakage? A pilot study | 1-gen-2012 | Teeuwen, P; de Geus-Oei, Lf; Hendriks, T; van Goor, H; Bremers, A; Oyen, W; Bleichrodt, R | |
| BEVACIZUMAB BEYOND PROGRESSION: HOW TO MONITOR TREATMENT EFFICACY? RESULTS OF A FUNCTIONAL IMAGING STUDY IN MURINE COLORECTAL CANCER | 1-gen-2012 | Heijmen, L; Ter Voert, Eegw; Punt, Cja; De Geus-Oei, L; Heerschap, A; Bussink, J; Zerbi, V; Oyen, W; Boerman, O; van Laarhoven, Hwm | |
| Monitoring the effects of bevacizumab beyond progression in murine colorectal cancer: a functional imaging approach | 1-gen-2012 | Heijmen, L; Punt, Cja; ter Voert, Eegw; de Geus-Oei, L; Heerschap, A; Bussink, J; Zerbi, V; Oyen, W; Span, Pn; Boerman, O; van Laarhoven, Hwm | |
| FLT-PET FOR DETECTION OF EARLY TREATMENT RESPONSE IN CERVICAL LYMPH NODE METASTASES OF HEAD AND NECK TUMOURS | 1-gen-2010 | Troost, E; Bussink, J; Oyen, W; Kaanders, J | |
| Fast and facile purification of Ga-68-labeled compounds using solid-phase extraction | 1-gen-2010 | Brom, M; Franssen, G; Joosten, L; Oyen, W; Gotthardt, M; Boerman, O | |
| Vessels encapsulating tumour clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma (HCC) | 1-gen-2019 | Renne, S; Woo, Hy; Rudini, N; Allegra, S; Yano, H; Donadon, M; Vigano, L; Akiba, J; Lee, Hs; Rhee, H; Park, Yn; Roncalli, M; Di Tommaso, L | |
| Sorafenib reduces the tumor uptake of Indium-111-girentuximab in clear cell renal cell carcinoma patients | 1-gen-2012 | Muselaers, Chj; Stillebroer, Ab; Boers-Sonderen, Mj; Desar, Ime; van Herpen, Cml; Langenhuijsen, Jf; Oosterwijk, E; Boerman, Oc; Mulders, Pfa; Oyen, W | |
| Pretargeting a radiolabeled hapten-peptide with a tri-Fab humanized bispecific antibody (bsMAb) to CEACAM5: First results in patients with colorectal cancer | 1-gen-2010 | Sharkey, R; Schoffelen, R; Esposito, G; He, Aw; Boerman, O; Oyen, W; Weiner, L; Goldenberg, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2151
Data di pubblicazione
- 2020 - 2026113
- 2010 - 20191340
- 2000 - 2009587
- 1990 - 1999110
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...120
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng794
- ita24
- und6
Accesso al fulltext
- no fulltext2098
- reserved51
- open2